Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Marilyn Benham"'
Autor:
Floris C. Loeff, Teresa Tsakok, Lisanne Dijk, Margreet H. Hart, Michael Duckworth, David Baudry, Alice Russell, Nick Dand, Astrid van Leeuwen, Christopher E.M. Griffiths, Nick J. Reynolds, Jonathan Barker, A. David Burden, Richard B. Warren, Annick de Vries, Karien Bloem, Gerrit Jan Wolbink, Catherine H. Smith, Theo Rispens, Marilyn Benham, David Burden, Ian Evans, Christopher Griffiths, Sagair Hussain, Brian Kirby, Linda Lawson, Kayleigh Mason, Kathleen McElhone, Ruth Murphy, Anthony Ormerod, Caroline Owen, Nick Reynolds, Catherine Smith, Richard Warren, Jonathan N.W.N. Barker, Michael R. Barnes, Paola DiMeglio, Richard Emsley, Andrea Evans, Katherine Payne, Deborah Stocken
Publikováno v:
Journal of investigative dermatology, 140(11), 2129-2137. Nature Publishing Group
Ustekinumab is an effective treatment for psoriasis, but response varies between patients. The formation of anti-drug antibodies (ADAs) may explain part of this variation by reducing the free ustekinumab level. Currently, published analyses of the cl
Autor:
Josh Richards, Marilyn Benham, Ian Evans, M.M. Soliman, Anthony Ormerod, Adèle C. Green, Tess McPherson, Nick J. Reynolds, C. M. Owen, Eleanor Pearson, Sagair Hussain, Philip Laws, Jonathan Barker, Christopher E.M. Griffiths, Linda Lawson, Teena Mackenzie, Catherine H. Smith, K.J. Mason, A D Burden, C.E. Kleyn, Ruth Murphy, Fiona Browne, Haibat Ali, Kathleen McElhone, Brian Kirby, Richard B. Warren, Mark Lunt
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADVReferences. 35(8)
There are concerns that immunomodulatory therapies may increase the risks of developing basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (SCC) in patients with moderate-severe psoriasis. A systematic review showed that psoriasis patie